NCT07605117 Isoinertial Training in Patients With COPD
| NCT ID | NCT07605117 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universidad Manuela Beltrán |
| Condition | COPD (Chronic Obstructive Pulmonary Disease) |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-05-07 |
| Primary Completion | 2026-07-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-05-07 with a primary completion date of 2026-07-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Isoinertial training is emerging as a potentially effective strategy to improve strength and functionality in older people diagnosed with chronic obstructive pulmonary disease (COPD), due to its influence on muscle mass and neuromuscular efficiency. COPD is characterized by systemic alterations, including peripheral muscle dysfunction; which contributes to patient functional limitation, and reduces patients' quality of life. Isoinertial training may improve the physiological response to effort, and also promote functional performance in this population. Hence, the aim of this study is to evaluate the effect of an isoinertial training program on muscle strength and functional capacity in patients with COPD during an 8-week intervention.
Eligibility Criteria
Inclusion Criteria: * People between 50 - 80 years of age diagnosed with moderate or severe COPD * No acute exacerbations in the last 4 weeks * Sufficient functional capacity to exercise * Signed informed consent Exclusion Criteria: * Presence of neurological, musculoskeletal, or cardiovascular diseases that significantly limit exercise performance or compromise participant safety; including uncontrolled hypertension, recent myocardial infarction, unstable angina, severe osteoarthritis, stroke sequelae, or Parkinson's disease. * Contraindications to exercise participation according to medical evaluation. * Recent surgeries in the past 3 months * Simultaneous participation in other exercise programs * Cognitive disorders
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07605117 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 80 Years, studying COPD (Chronic Obstructive Pulmonary Disease). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07605117 currently recruiting?
Yes, NCT07605117 is actively recruiting participants. Contact the research team at david.murcia@docentes.umb.edu.co for enrollment information.
Where is the NCT07605117 trial being conducted?
This trial is being conducted at Bogotá, Colombia, Ibague, Colombia.
Who is sponsoring the NCT07605117 clinical trial?
NCT07605117 is sponsored by Universidad Manuela Beltrán. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.